By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Statistics

Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD


Company News
Why Gilead (GILD) and Roche (RHHBY) Should Take a Good Look at Clovis Oncology (CLVS) as Possible M&A Target 10/6/2015 7:04:18 AM
Gilead (GILD) Scores FDA Approval of Letairis Combo as PAH Treatment 10/5/2015 6:47:16 AM
ContraVir Pharmaceuticals Reports New Data Demonstrating CMX157 To Be 60-Fold More Potent Against Hepatitis B Virus Than Gilead (GILD)'s Viread 10/5/2015 6:24:40 AM
European CHMP Adopts Positive Opinion For Gilead (GILD)’s Single Tablet Regimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofovir Alafenamide) For The Treatment Of HIV 9/25/2015 6:06:20 AM
Gilead (GILD) Beats AbbVie (ABBV) Again 9/22/2015 7:01:27 AM
Why Gilead (GILD) Is A Buy (Hint: It's Not Hepatitis C) 9/21/2015 7:17:07 AM
Gilead (GILD) Reports Positive Update on Four Sofosbuvir Combo Phase IIIs in Certain HCV 9/21/2015 6:54:35 AM
Gilead (GILD) To Present At The Morgan Stanley Global Healthcare Conference On Wednesday, September 16 9/16/2015 3:27:11 PM
Encouraging Results From Real-World Users Of Gilead (GILD)'s HIV-Prevention Pill Truvada 9/14/2015 7:50:58 AM
Gilead (GILD) Borrows $10 Billion, Spurring Acquisition Speculation 9/10/2015 6:08:07 AM